Wealthcare Advisory Partners LLC Crispr Therapeutics Ag Transaction History

Wealthcare Advisory Partners LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$60.67 - $89.12 $18,201 - $26,736	300 Added 7.69%	4,200 $286,000
Q4 2023 Feb 06, 2024	BUY	$38.62 - $72.18 $150,618 - $281,502	3,900 New	3,900 $244,000
Q2 2023 Jul 17, 2023	BUY	$43.47 - $67.77 $169,533 - $264,303	3,900 New	3,900 $218,000
Q4 2021 Feb 11, 2022	SELL	$70.09 - $111.29 $154,198 - $244,838	-2,200 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $22,040 - $31,327	200 Added 10.0%	2,200 $246,000
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $78,655 - $126,274	780 Added 63.93%	2,000 $324,000
Q1 2021 Apr 30, 2021	BUY	$110.72 - $210.04 $135,078 - $256,248	1,220 New	1,220 $149,000
Q2 2020 Jul 29, 2020	SELL	$38.5 - $76.05 $20,982 - $41,447	-545 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$33.68 - $62.53 $11,788 - $21,885	350 Added 179.49%	545 $23,000
Q3 2019 Oct 17, 2019	BUY	$40.99 - $52.56 $1,639 - $2,102	40 Added 25.81%	195 $8,000
Q3 2018 Nov 14, 2018	SELL	$44.35 - $65.71 $709 - $1,051	-16 Reduced 9.36%	155 $7,000
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $6,606 - $11,406	155 Added 968.75%	171 $10,000
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $376 - $930	16 New	16 $1,000

488

60.3M

1.26M

1.81M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.